Your browser doesn't support javascript.
loading
Do we know more about hypertension in Poland after the May Measurement Month 2017?-Europe.
Malyszko, Jolanta; Mastej, Miroslaw; Banach, Maciej; Tykarski, Andrzej; Narkiewicz, Krzysztof; Hoffman, Piotr; Jankowski, Piotr; Nowicki, Michal P; Tomasik, Tomasz; Windak, Adam; Olszanecka, Agnieszka; Motyl, Agnieszka; Nowak, Dariusz; Skowron, Lukasz; Tomaszewski, Maciej; Beaney, Thomas; Xia, Xin; Nillson, Peter; Poulter, Neil R; Józwiak, Jacek.
Afiliação
  • Malyszko J; Department of Nephrology, Dialysis and Internal Medicine, Warsaw Medical University, Banacha 1a, 02-097 Warszawa, Poland.
  • Mastej M; Mastej Medical Center, Staszica 21, 38-200 Jaslo, Poland.
  • Banach M; Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Zeromskiego 113, 90-549 Lodz, Poland.
  • Tykarski A; Department of Hypertension, Angiology and Internal Medicine, Poznan University of Medical Sciences, Dluga1/2, 61-848 Poznan, Poland.
  • Narkiewicz K; Department of Hypertension and Diabetology, Medical University of Gdansk, Debinki 7, 80-952 Gdansk, Poland.
  • Hoffman P; Department of Congenital Heart Disease, Institute of Cardiology, Alpejska 42, 04-628 Warszawa, Poland.
  • Jankowski P; I Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kopernika 17, 31-501 Kraków, Poland.
  • Nowicki MP; Department of Nephrology, Hypertension and Kidney Transplantation, Medical University of Lodz, Pomorska 251, 92-213 Lodz, Poland.
  • Tomasik T; Department of Family Medicine, Chair of Internal Medicine and Gerontology, Jagiellonian University Medical College, Bochenska 4, 31-061 Kraków, Poland.
  • Windak A; Department of Family Medicine, Chair of Internal Medicine and Gerontology, Jagiellonian University Medical College, Bochenska 4, 31-061 Kraków, Poland.
  • Olszanecka A; I Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kopernika 17, 31-501 Kraków, Poland.
  • Motyl A; Medicover Poland, Jerozolimskie 96, 00-807 Warszawa, Poland.
  • Nowak D; Municipal Hospital, Mickiewicza 12, 42-200 Czestochowa, Poland.
  • Skowron L; Department of Gastroenterology, Endocrinology and Internal Diseases, Military Institute of Medicine, Szaserów 128, 04-141 Warszawa, Poland.
  • Tomaszewski M; Division of Cardiovascular Sciences, University of Manchester, 46 Grafton Street, Manchester M13 9NT, UK.
  • Beaney T; Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, W12 7RH, UK.
  • Xia X; Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, W12 7RH, UK.
  • Nillson P; Lund University, Skane University Hospital, Malmo, Sweden.
  • Poulter NR; Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, W12 7RH, UK.
  • Józwiak J; Department of Family Medicine and Public Health, Institute of Medicine, University of Opole, Oleska 48, 45-052 Opole, Poland.
Eur Heart J Suppl ; 21(Suppl D): D97-D100, 2019 Apr.
Article em En | MEDLINE | ID: mdl-31043891
ABSTRACT
Elevated blood pressure (BP) is a worldwide burden, leading to over 10 million deaths yearly. May Measurement Month (MMM) is a global initiative organized by the International Society of Hypertension aimed at raising awareness of hypertension and the need for BP screening. An opportunistic cross-sectional survey of volunteers aged ≥18 was carried out in May 2017. BP measurement, the definition of hypertension and statistical analysis followed the globally approved MMM17 Study Protocol. In Poland 5834 (98.9%, Caucasian) individuals were screened. After multiple imputation, 2601 (35.3%) had hypertension. Of individuals not receiving anti-hypertensive medication, 976 (20.6%) were hypertensive. Of individuals receiving anti-hypertensive medication, 532 (49.1%) had uncontrolled BP. In the crude screened group, 81.4% declared to not receive any anti-hypertensive treatment, while the remaining 18.6% were on such medications. In overweight and obese patients both systolic and diastolic BP were significantly higher than in normal weight and underweight subjects. In addition, BP measured on Sundays was significantly lower than on Mondays. MMM17 was one of the largest recent BP screening campaigns in Poland. We found that over 1/3 of participants were hypertensive. Almost half of the treated subjects had uncontrolled BP. These results suggest that opportunistic screening can identify substantial numbers with raised BP.

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Eur Heart J Suppl Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Polônia

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Eur Heart J Suppl Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Polônia